We are live on
!
Find out more
RP
Rowlandmiller & Partners Portfolio holdings
AUM
$549M
1-Year Est. Return
36.2%
This Fund
S&P 500
This Quarter
Est. Return
-9.63%
1 Year Est. Return
+36.2%
3 Year Est. Return
+84%
5 Year Est. Return
+107.35%
10 Year Est. Return
+338.51%
AUM
$247M
AUM Growth
-$29.8M
(-11%)
Cap. Flow
+$3.85M
Cap. Flow
% of AUM
1.56%
Top 10 Holdings %
Top 10 Hldgs %
36.49%
Holding
139
New
2
Increased
66
Reduced
34
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$8.97M |
| 2 |
Intel
INTC
|
+$447K |
| 3 |
Cintas
CTAS
|
+$392K |
| 4 |
Apple
AAPL
|
+$356K |
| 5 |
Coca-Cola
KO
|
+$343K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$6.38M |
| 2 |
MiMedx Group
MDXG
|
+$1.14M |
| 3 |
United Natural Foods
UNFI
|
+$1.01M |
| 4 |
Schwab International Equity ETF
SCHF
|
+$590K |
| 5 |
AT&T
T
|
+$264K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.61% |
| 2 | Healthcare | 14.72% |
| 3 | Financials | 14.47% |
| 4 | Consumer Staples | 13.23% |
| 5 | Consumer Discretionary | 12.36% |
Similar funds
AMG
AI
LWP
WCP
BCM
HIS
AA
V
Rowlandmiller & Partners's Q4 2018 Portfolio in Review
As of Q4 2018, Rowlandmiller & Partners held 139 positions worth $247M, down 11% from $277M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Rowlandmiller & Partners's Q4 2018 filing shows 2 new, 66 increased, 34 reduced and 9 closed positions. Its largest new stake was NVIDIA: 32,000 shares worth $107K. The largest sale was JPMorgan Chase, an estimated $6.38M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Rowlandmiller & Partners's largest Q4 2018 buy was NVIDIA: 32,000 shares worth $107K.
- Rowlandmiller & Partners added most to Johnson & Johnson in Q4 2018, an estimated $8.97M increase.
- Rowlandmiller & Partners's biggest Q4 2018 reduction was JPMorgan Chase, cutting an estimated $6.38M.
- Rowlandmiller & Partners fully exited MiMedx Group in Q4 2018, selling an estimated $1.14M.
- Rowlandmiller & Partners's ten largest holdings make up 36% of its $247M portfolio in Q4 2018.
- Rowlandmiller & Partners opened 2 new positions and closed 9 in Q4 2018.
- Rowlandmiller & Partners's portfolio value fell 11% quarter-over-quarter to $247M.
Based on Rowlandmiller & Partners's 13F filing for Q4 2018, filed 12 Feb 2019.